- Posts not found
Familial RUNX1 Grant Program
ALSF is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers. The RUNX1 Research Program (runx1.com) is dedicated to advancing areas of research of particular importance to families affected by familial platelet disorders (FPDs) leading to acute myeloid leukemia (AML) due to germline RUNX1 mutations with the ultimate goal of developing effective therapies to prevent the onset of AML.
Application Deadlines: December 26, 2019